CoChat

Predictors of Benzodiazepine Discontinuation in Subjects Manifesting Complicated Dependence

The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.

Abstract

We described characteristics of subjects with benzodiazepine dependence that was typically complicated by harmful and hazardous alcohol use or high benzodiazepine doses, and assessed predictors of successful discontinuation of benzodiazepines for this group. Seventy-six patients who participated in a randomized clinical trial of two different gradual withdrawal treatment approaches were assessed. The trial was conducted between February 1995 and July 1999. The mean age +/- SD of subjects was 40.0 +/- 9.6 years, 55% were male, 38% were married or cohabiting, and 70% had received more than nine years of education. The median benzodiazepine dose was 35 mg/day (range 2.5-180) in diazepam equivalents. The median duration of benzodiazepine use was 84 (range 8-360) months. Subjects with lower benzodiazepine doses and no previous withdrawal attempts were more successful at benzodiazepine discontinuation. Cluster B personality/borderline personality disorder was associated with an inability to stop benzodiazepine use and with "dropping out" of treatment. Alcohol use-related disorders or other psychiatric diagnoses were not associated with outcome. Further studies on predictors of successful benzodiazepine discontinuation in different populations are required. Patients manifesting cluster B personality/borderline personality disorder and benzodiazepine dependence may need concomitant treatment for their personality disorders to benefit from benzodiazepine discontinuation treatment.

Overview

Integrity signals

Registry

Crossref · 10.1081/ja-200052433

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 38 references

Research works printed but not linked: 7

  1. Ciraulo D. A., 1998, American Journal of Psychiatry, 145, 1501
  2. de l as, 2002, Addiction, 95, 245
  3. Derogatis L. R., 1973, Psychopharmacology Bulletin, 9, 13
  4. Gossop M., 1995, Addiction, 90, 607, 10.1111/j.1360-0443.1995.tb02199.x · DOI · Paper page
  5. Rickels K., 1988, Psychopharmacology Bulletin, 24, 415
  6. Spitzer R., 1985, Structured Clinical Interview for DSM-III-R, Patient Version
  7. Spitzer R., 1990, Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II)

Cited by

Metadata

Authors
VORMA, H., NAUKKARINEN, H. H., SARNA, S. J., & KUOPPASALMI, K. I.
Affiliations
  • A-Clinic Foundation (FI)
  • Helsinki University Hospital (FI)
  • University of Helsinki (FI)
Venue
Substance Use & Misuse
Published
2005-01
Volume
40
Issue
4
Pages
499-510
ISSN
  • 1082-6084 (ISSN-L)
  • 1532-2491
OpenAlex
W2018262147
Cited by
22
References
39
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 3
FWCI
0.95
Type
journal article
Language
en
Open access
closed
Locations
  • Substance Use & Misuse (publishedVersion)
  • PubMed (publishedVersion)
Funders
Alkoholitutkimussäätiö
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
benzodiazepine dependence, benzodiazepine discontinuation, predictors of treatment outcome, cluster B personality disorders, borderline personality disorder, alcoholism, treatment discontinuation, personality disorder comorbidity
MeSH terms
Adult, Alcoholism, Anticonvulsants, Benzodiazepines, Diazepam, Female, Humans, Male, Personality Disorders, Quality of Life, Surveys and Questionnaires, Severity of Illness Index, Time Factors, Substance-Related Disorders, Diagnostic and Statistical Manual of Mental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.